SCHEMBL14509143

SCHEMBL14509143

CCCCCC[C@H](CP(=O)(O)[C@@H](NC(=O)CCc1ccccc1)C(C)C)C(=O)O

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CPB2 Q96IY4 1/20 0.83
▸ CPA1 P15085 7/20 0.46
▸ CPA2 P48052 7/20 0.46
▸ CPA4 Q9UI42 7/20 0.46
▸ HPGD P15428 1/20 0.46
▸ HDAC3 O15379 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ MMP2 P08253 1/20 0.42
▸ MMP3 P08254 1/20 0.42
▸ CNR2 P34972 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14542979 0.91 CPB2 (1.00) CPB2CPA1CPA2CPA4MMP3
SCHEMBL6824195 0.91 CPB2 (1.00) CPB2CPA1CPA2CPA4MMP3
SCHEMBL6824349 0.90 CPB2 (0.98) CPB2CPA1CPA2CPA4MMP3
SCHEMBL6827926 0.90 CPB2 (0.98) CPB2CPA1CPA2CPA4MMP3
SCHEMBL6827930 0.90 CPB2 (0.98) CPB2CPA1CPA2CPA4MMP3
SCHEMBL6827315 0.83 CPB2 (0.70) CPB2MMP3
SCHEMBL6827301 0.78 CPB2 (0.59) CPB2HDAC3MMP3HDAC1HDAC2
SCHEMBL6827328 0.76 CPB2 (0.58) CPB2HDAC3SMN1; SMN2LMNACYP1A2
SCHEMBL2354768 0.72 CPB2 (0.60) CPB2SMN1; SMN2LMNACYP1A2CYP3A4
SCHEMBL6827198 0.72 CPB2 (0.68) CPB2CPA1CPA2CPA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070111947-A1 Fibrin targeted therapeutics MCMURRY THOMAS J 2007-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070111947-A1 Fibrin targeted therapeutics FGB, F13B, F2 CPB2 202/4885CPA1 737/4885CPA2 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback